Swedish Orphan Biovitrum AB (publ)

DB:B6E0 Stock Report

Market Cap: €9.0b

Swedish Orphan Biovitrum Past Earnings Performance

Past criteria checks 1/6

Swedish Orphan Biovitrum's earnings have been declining at an average annual rate of -4.9%, while the Biotechs industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 12.3% per year. Swedish Orphan Biovitrum's return on equity is 5.9%, and it has net margins of 9%.

Key information

-4.9%

Earnings growth rate

-6.9%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate12.3%
Return on equity5.9%
Net Margin9.0%
Next Earnings Update24 Oct 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Swedish Orphan Biovitrum makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:B6E0 Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2423,7102,14510,6093,257
31 Mar 2423,1402,14210,2012,903
31 Dec 2322,1232,4099,7732,743
30 Sep 2321,2702,7698,9512,594
30 Jun 2320,1003,1258,2022,358
31 Mar 2319,1043,1627,8592,371
31 Dec 2218,7902,6387,6372,252
30 Sep 2217,6962,4937,3402,156
30 Jun 2217,4582,5167,0772,116
31 Mar 2216,7932,5266,6672,042
31 Dec 2115,5292,6796,2941,987
30 Sep 2115,2142,9406,0221,926
30 Jun 2114,4242,7445,8681,845
31 Mar 2114,2832,7595,8761,706
31 Dec 2015,2613,2455,9811,594
30 Sep 2015,5703,1035,8941,418
30 Jun 2015,5303,3675,6151,306
31 Mar 2015,6223,5835,3581,475
31 Dec 1914,2483,3044,8071,448
30 Sep 1911,9292,5394,0931,466
30 Jun 1911,3132,6203,5781,460
31 Mar 1910,4402,8062,9521,189
31 Dec 189,1392,4182,5111,090
30 Sep 188,4432,1812,335991
30 Jun 187,7291,8812,206918
31 Mar 187,0791,4622,136923
31 Dec 176,5111,1492,084908
30 Sep 175,9278652,018937
30 Jun 175,4976771,963902
31 Mar 175,3277031,861858
31 Dec 165,2048021,776778
30 Sep 164,7277161,633654
30 Jun 164,3415851,539595
31 Mar 163,6362911,463519
31 Dec 153,228651,345513
30 Sep 153,119591,263528
30 Jun 153,0001081,177499
31 Mar 152,8991361,094505
31 Dec 142,607-2681,031500
30 Sep 142,513-2631,007453
30 Jun 142,364-373971475
31 Mar 142,221-410933463
31 Dec 132,177-93896456

Quality Earnings: B6E0 has high quality earnings.

Growing Profit Margin: B6E0's current net profit margins (9%) are lower than last year (15.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: B6E0's earnings have declined by 4.9% per year over the past 5 years.

Accelerating Growth: B6E0's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: B6E0 had negative earnings growth (-31.4%) over the past year, making it difficult to compare to the Biotechs industry average (-13.8%).


Return on Equity

High ROE: B6E0's Return on Equity (5.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies